JPH09511997A - ベンザミド誘導体、該誘導体を含む組成物およびその使用 - Google Patents
ベンザミド誘導体、該誘導体を含む組成物およびその使用Info
- Publication number
- JPH09511997A JPH09511997A JP7526693A JP52669395A JPH09511997A JP H09511997 A JPH09511997 A JP H09511997A JP 7526693 A JP7526693 A JP 7526693A JP 52669395 A JP52669395 A JP 52669395A JP H09511997 A JPH09511997 A JP H09511997A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- agent
- remainder
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/58—Nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式 (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物。 2.式 (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物を有効成分として含有する医薬組成物。 3.式 (式中、R1=OHおよびR2=R3=R4=R5=Hである) の化合物Aおよび式 の化合物Bの混合物を有効成分として含有する、請求項2の医薬組成物。 4.湿潤剤をさらに含有する経口投与用の請求項2または3の医薬組成物。 5.少なくとも1つの湿潤剤がアニオン界面活性剤からなる群から選ばれる、 請求項4の医薬組成物。 6.湿潤剤が糖エステル、ポリオキシエチレン、ポリオキシプロピレン、アン ヒドロヘキシトール誘導体、脂肪アルカノールアミド、脂肪アミンオキシド、ス クロース、マンニトール、ソルビトール、レシチン、ポリビニルピロリドン、脂 肪酸エステル、スクロースのグリセリド、キシロースのエステル、ポリオキシエ チレングリセリド、脂肪酸のエステル、脂肪アルコールのポリオキシエチレンエ ーテル、ソルビタンのポリオキシエチレン脂肪酸エステル、ソルビタンの脂肪酸 のポリオキシエチレンエステル、アルコールポリグリセリドのグリセリド−ポリ グリセリドエステルおよびこれらの混合物からなる群から選択される請求項4の 医薬組成物。 7.でんぷん誘導体を含有する、請求項1−6のいずれかの医薬組成物。 8.カルボキシメチルでんぷんまたはその塩を含有する、請求項7の医薬組成 物。 9.有効成分の重量に対し20重量%までの界面活性剤および有効成分の重量 に対し20重量%までのでんぷん誘導体を含む、請求項4の組成物。 10.*式I (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物の有効量、それと場合により混合された式 の化合物B *湿潤剤および *でんぷん誘導体 を含む組成物を含む核からなり、その組成物の水含量が25重量%以下である、 経口投与用の製剤処方。 11.カルボキシメチルでんぷんまたはその塩を含有する請求項10の処方。 12.*式I (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物の有効量、それと場合により混合される式 の化合物Bおよび *湿潤剤 を含有する、下腹部の感染に対する処置のための軟膏。 13.でんぷん誘導体を含む請求項12の軟膏。 14.式 (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物の抗寄生虫剤としての使用。 15.式 (式中、R1=OHおよびR2=R3=R4=R5=Hである) の化合物Aおよび式 の化合物Bの混合物の抗寄生虫剤としての使用。 16.式I (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物の抗菌剤としての使用。 17.式 (式中、R1=OHおよびR2=R3=R4=R5=Hである) の化合物Aおよび式 の化合物Bの混合物の抗菌剤としての使用。 18.式I (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物の抗真菌剤としての使用。 19.式 (式中、R1=OHおよびR2=R3=R4=R5=Hである) の化合物Aおよび式 の化合物の混合物の抗真菌剤としての使用。 20.式I (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物の抗ウイルス剤としての使用。 21.式 (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の化合物の抗ウイルス剤としての使用。 22.式 (式中、R1=OHおよびR2=R3=R4=R5=Hである) の化合物Aおよび式 の化合物の混合物の抗ウイルス剤としての使用。 23.*式I (式中、R1、R2、R3、R4およびR5の1つはOHであり、残りはHである) の有効成分の有効量 *場合により式 の化合物B *場合によりでんぷん誘導体 を保存剤として含有する食品組成物。
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/227,033 | 1994-04-13 | ||
US08/227,033 US5387598A (en) | 1994-04-13 | 1994-04-13 | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
US08/301,407 | 1994-09-08 | ||
US08/301,407 US5578621A (en) | 1994-09-08 | 1994-09-08 | Benzamide derivatives |
US38385595A | 1995-02-06 | 1995-02-06 | |
US08/383,855 | 1995-02-06 | ||
US301,407 | 1995-02-06 | ||
US383,855 | 1995-02-06 | ||
US227,033 | 1995-02-06 | ||
PCT/EP1995/001334 WO1995028393A1 (en) | 1994-04-13 | 1995-04-11 | Benzamide derivative, compositions containing said derivative and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09511997A true JPH09511997A (ja) | 1997-12-02 |
JP3224395B2 JP3224395B2 (ja) | 2001-10-29 |
Family
ID=27397680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52669395A Expired - Lifetime JP3224395B2 (ja) | 1994-04-13 | 1995-04-11 | ベンザミド誘導体、該誘導体を含む組成物およびその使用 |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0755386B1 (ja) |
JP (1) | JP3224395B2 (ja) |
KR (2) | KR100348440B1 (ja) |
CN (1) | CN1072654C (ja) |
AP (1) | AP645A (ja) |
AT (1) | ATE218557T1 (ja) |
AU (1) | AU689582B2 (ja) |
BG (1) | BG62932B1 (ja) |
BR (1) | BR9507371A (ja) |
CA (1) | CA2187110C (ja) |
CZ (1) | CZ287002B6 (ja) |
DE (1) | DE69526936T2 (ja) |
DK (1) | DK0755386T3 (ja) |
ES (1) | ES2161201T3 (ja) |
FI (1) | FI120258B (ja) |
HU (1) | HUT77404A (ja) |
NZ (1) | NZ284800A (ja) |
OA (1) | OA10463A (ja) |
PL (1) | PL186504B1 (ja) |
PT (1) | PT755386E (ja) |
RU (1) | RU2140915C1 (ja) |
SI (1) | SI0755386T1 (ja) |
SK (1) | SK281949B6 (ja) |
WO (1) | WO1995028393A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009522371A (ja) * | 2006-01-09 | 2009-06-11 | ロマーク ラボラトリーズ エル.シー. | ウイルス性肝炎の処置 |
JP2012531420A (ja) * | 2009-06-26 | 2012-12-10 | ロマーク ラボラトリーズ エル.シー. | インフルエンザを治療するための化合物および方法 |
JP2016006053A (ja) * | 2009-05-12 | 2016-01-14 | ロマーク ラボラトリーズ エル.シー. | ハロアルキルヘテロアリールベンズアミド化合物 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968961A (en) | 1997-05-07 | 1999-10-19 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
US5856348A (en) * | 1994-09-08 | 1999-01-05 | Romark Laboratories, L.C. | Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide |
CA2467321A1 (en) | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
CA2574282A1 (en) | 2004-07-21 | 2006-03-02 | Dana-Farber Cancer Institute, Inc. | Lentiviral vectors and uses thereof |
UA90864C2 (en) * | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
BRPI0815057B8 (pt) | 2007-08-03 | 2021-05-25 | Romark Laboratories Lc | composto, composição farmacêutica, e, uso de um composto |
CA2778182C (en) | 2009-10-22 | 2018-04-17 | Thomas Julius Borody | Novel parasite therapy |
CN104094927B (zh) * | 2013-04-02 | 2016-06-01 | 兴邦(武汉)生物科技有限公司 | 一种处理植物的助剂组合物 |
TW201630606A (zh) * | 2015-01-21 | 2016-09-01 | 諾華公司 | 包含局部藥物之蓋崙(galenic)調配物 |
WO2019148291A1 (en) | 2018-02-02 | 2019-08-08 | Interface Biologics, Inc. | Ocular inserts comprising a covalently linked steroid dimer |
WO2021220061A2 (en) | 2020-05-01 | 2021-11-04 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
EP4337200A1 (en) * | 2021-05-28 | 2024-03-20 | Henderson, Theodore | Treatment using an antiviral compound and nitazoxanide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1306603A (fr) * | 1958-08-14 | 1962-10-19 | Innothera Lab Sa | Dérivés thiazoliques et leur procédé de préparation |
FR716M (ja) * | 1960-08-05 | 1961-08-07 | ||
GB1437800A (en) * | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
FR2435905A1 (fr) * | 1978-09-13 | 1980-04-11 | Anvar | Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole |
US4315018A (en) * | 1978-12-07 | 1982-02-09 | Rossignol Jean F | Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives |
US4447414A (en) * | 1982-12-21 | 1984-05-08 | Cutter Laboratories, Inc. | Carnivore anthelmintics |
-
1995
- 1995-04-11 KR KR1019960705785A patent/KR100348440B1/ko not_active IP Right Cessation
- 1995-04-11 CZ CZ19962959A patent/CZ287002B6/cs not_active IP Right Cessation
- 1995-04-11 DE DE69526936T patent/DE69526936T2/de not_active Revoked
- 1995-04-11 HU HU9602798A patent/HUT77404A/hu unknown
- 1995-04-11 KR KR10-2000-7003874A patent/KR100373081B1/ko not_active IP Right Cessation
- 1995-04-11 BR BR9507371A patent/BR9507371A/pt not_active IP Right Cessation
- 1995-04-11 SI SI9530607T patent/SI0755386T1/xx unknown
- 1995-04-11 NZ NZ284800A patent/NZ284800A/en not_active IP Right Cessation
- 1995-04-11 PT PT95917310T patent/PT755386E/pt unknown
- 1995-04-11 PL PL95316757A patent/PL186504B1/pl not_active IP Right Cessation
- 1995-04-11 AU AU23440/95A patent/AU689582B2/en not_active Ceased
- 1995-04-11 EP EP95917310A patent/EP0755386B1/en not_active Revoked
- 1995-04-11 AT AT95917310T patent/ATE218557T1/de not_active IP Right Cessation
- 1995-04-11 DK DK95917310T patent/DK0755386T3/da active
- 1995-04-11 AP APAP/P/1996/000866A patent/AP645A/en active
- 1995-04-11 JP JP52669395A patent/JP3224395B2/ja not_active Expired - Lifetime
- 1995-04-11 WO PCT/EP1995/001334 patent/WO1995028393A1/en not_active Application Discontinuation
- 1995-04-11 CN CN95192524A patent/CN1072654C/zh not_active Expired - Fee Related
- 1995-04-11 CA CA002187110A patent/CA2187110C/en not_active Expired - Lifetime
- 1995-04-11 SK SK1307-96A patent/SK281949B6/sk not_active IP Right Cessation
- 1995-04-11 ES ES95917310T patent/ES2161201T3/es not_active Expired - Lifetime
- 1995-04-11 RU RU96119364A patent/RU2140915C1/ru not_active IP Right Cessation
-
1996
- 1996-10-03 BG BG100884A patent/BG62932B1/bg unknown
- 1996-10-04 OA OA60900A patent/OA10463A/en unknown
- 1996-10-08 FI FI964031A patent/FI120258B/fi not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009522371A (ja) * | 2006-01-09 | 2009-06-11 | ロマーク ラボラトリーズ エル.シー. | ウイルス性肝炎の処置 |
JP2016006053A (ja) * | 2009-05-12 | 2016-01-14 | ロマーク ラボラトリーズ エル.シー. | ハロアルキルヘテロアリールベンズアミド化合物 |
JP2012531420A (ja) * | 2009-06-26 | 2012-12-10 | ロマーク ラボラトリーズ エル.シー. | インフルエンザを治療するための化合物および方法 |
JP2016172749A (ja) * | 2009-06-26 | 2016-09-29 | ロマーク ラボラトリーズ エル.シー. | インフルエンザを治療するための化合物および方法 |
JP2017197552A (ja) * | 2009-06-26 | 2017-11-02 | ロマーク ラボラトリーズ エル.シー. | インフルエンザを治療するための化合物および方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09511997A (ja) | ベンザミド誘導体、該誘導体を含む組成物およびその使用 | |
MXPA96004483A (en) | Derivatives of benzamide, compositions that contain such derivative and use of the mis | |
US5886013A (en) | Antiviral composition | |
LT4751B (lt) | Tizoksanido ir nitazoksanido farmacinės kompozicijos | |
DK166715B1 (da) | Farmaceutiske produkt og anvendelse af dette til fremstilling af et kombinationspraeparat til behandling af virusinfektioner | |
CA2873390C (en) | Complex compounds of germanium, methods for producing same, and drugs | |
KR20010020322A (ko) | 티조사나이드 및 니타조사나이드의 약물 혼합물 | |
US6051579A (en) | Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection | |
DE10044353A1 (de) | Unkompetitive Inhibitoren der Helikase-Primase | |
RO118293B1 (ro) | Derivat de benzamida, compozitii continand acest derivat si utilizarea acestuia | |
MXPA00010855A (es) | Uso de derivados de benzamida como agentes parasitarios, antibacterianos, antivirales y antifungicos | |
WO1994014457A1 (en) | Compositions effective against acyclovir-resistant strains of herpes viruses | |
KR800001505B1 (ko) | 티아졸릴 페닐구아니딘류의 제조방법 | |
EP0766560A1 (en) | Use of thioketene derivatives for preventing or treating hepatitis b | |
WO1996014847A1 (en) | Use of phosphonoacetic or-formic acids against human herpes virus -7 (hhv-7) | |
JPH02149524A (ja) | ひと免疫不全ウイルス性疾患処置剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080824 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080824 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090824 Year of fee payment: 8 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090824 Year of fee payment: 8 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090824 Year of fee payment: 8 |
|
S201 | Request for registration of exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R314201 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090824 Year of fee payment: 8 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090824 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100824 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110824 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110824 Year of fee payment: 10 |
|
S804 | Written request for registration of cancellation of exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R314805 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110824 Year of fee payment: 10 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120824 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130824 Year of fee payment: 12 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |